Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 242

Results For "improve"

2617 News Found

Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
News | November 12, 2021

Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22

Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.


J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22
News | November 12, 2021

J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22

J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021


Clinical study shows ViroStop spray prevents Covid-19
News | November 11, 2021

Clinical study shows ViroStop spray prevents Covid-19

Evidence also shows better immune response to virus among users of spray


Takeda receives the Arogaya CIBioD Leadership Award
Public Health | November 10, 2021

Takeda receives the Arogaya CIBioD Leadership Award

It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients


IVD system to assist assay developers and clinical labs for molecular diagnostics
Medical Device | November 10, 2021

IVD system to assist assay developers and clinical labs for molecular diagnostics

Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow


Strides Pharma Science incurs Rs 162.55 cr. loss in Q2FY22
News | November 10, 2021

Strides Pharma Science incurs Rs 162.55 cr. loss in Q2FY22

Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021


Bristol Myers neoadjuvant Opdivo (nivolumab) plus chemotherapy assists cancer patients effectively
Biotech | November 09, 2021

Bristol Myers neoadjuvant Opdivo (nivolumab) plus chemotherapy assists cancer patients effectively

Positive results reinforce the improved efficacy seen with Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer and melanoma


Novaerus devices reduce bio-burden in healthcare facilities: Dilip Patil, Partner, Trivector Biomed
interviews | November 05, 2021

Novaerus devices reduce bio-burden in healthcare facilities: Dilip Patil, Partner, Trivector Biomed

Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.


UK authorises first Covid-19 pill
News | November 05, 2021

UK authorises first Covid-19 pill

Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency


Built-for-purpose offering for biomolecule attribute monitoring
Medical Device | November 02, 2021

Built-for-purpose offering for biomolecule attribute monitoring

The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity